S&P 500
(-0.46%) 4 988.31 points
Dow Jones
(0.58%) 37 996 points
Nasdaq
(-1.35%) 15 391 points
Oil
(0.93%) $83.50
Gas
(0.06%) $1.758
Gold
(0.65%) $2 413.50
Silver
(1.30%) $28.75
Platinum
(-1.11%) $943.90
USD/EUR
(-0.09%) $0.938
USD/NOK
(-0.21%) $11.02
USD/GBP
(0.39%) $0.807
USD/RUB
(-1.02%) $92.94

Realtime updates for BIG PHARMA SPLIT CORP [PRM.TO]

Exchange: TSX Industry: Asset Management
Last Updated19 Apr 2024 @ 13:03

0.45% $ 13.36

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 13:03):

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States...

Stats
Today's Volume 1 130.00
Average Volume 1 164.00
Market Cap 15.54M
EPS $0 ( 2023-03-30 )
Last Dividend $0.103 ( 2023-08-30 )
Next Dividend $0 ( N/A )
P/E -25.21
ATR14 $0 (0.00%)

BIG PHARMA SPLIT CORP Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BIG PHARMA SPLIT CORP Financials

Annual 2023
Revenue: $311 764
Gross Profit: $311 764 (100.00 %)
EPS: $0
Q2 2023
Revenue: $-199 204
Gross Profit: $-199 204 (100.00 %)
EPS: $-0.230
Q1 2023
Revenue: $-199 204
Gross Profit: $-199 204 (100.00 %)
EPS: $-0.230
Q4 2022
Revenue: $1.52M
Gross Profit: $1.52M (100.00 %)
EPS: $0.110

Financial Reports:

No articles found.

BIG PHARMA SPLIT CORP Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.309
(N/A)
$0.309
(N/A)
$0.309
(N/A)
$0.309
(N/A)
$0.206
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

BIG PHARMA SPLIT CORP Dividend Information - Dividend King

Dividend Sustainability Score: 2.52 - low (50.00%) | Divividend Growth Potential Score: 2.24 - Decrease likely (55.15%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.103 2017-12-28
Last Dividend $0.103 2023-08-30
Next Dividend $0 N/A
Payout Date 2023-09-08
Next Payout Date N/A
# dividends 71 --
Total Paid Out $7.93 --
Avg. Dividend % Per Year 5.77% --
Score 5.73 --
Div. Sustainability Score 2.52
Div.Growth Potential Score 2.24
Div. Directional Score 2.38 --
Next Divdend (Est)
(2024-07-01)
$0 Estimate 21.60 %
Dividend Stability
0.58 Average
Dividend Score
5.73
Pay Frequency
Monthly
Yearly Payout
Year Amount Yield
2017 $0 0.00%
2018 $1.236 8.91%
2019 $1.236 9.94%
2020 $1.339 9.72%
2021 $1.952 14.30%
2022 $1.236 8.55%
2023 $0.824 5.65%
2024 $0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for TSX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
VIDY.TO Dividend Junior 2023-06-30 Quarterly 6 2.20%
NBLY.TO Dividend Junior 2023-08-28 Quarterly 4 0.34%
DRMC.TO Dividend Junior 2023-09-21 Quarterly 7 1.61%
ZDB.TO Dividend King 2023-08-29 Monthly 11 1.29%
SIS.TO Dividend King 2023-09-28 Monthly 20 1.94%
HMMJ.TO Dividend Junior 2023-06-29 Semi-Annually 8 1.15%
BTO.TO Dividend Knight 2023-09-20 Quarterly 6 2.27%
XCD.TO Dividend Junior 2023-06-26 Semi-Annually 12 0.34%
PDV.TO Dividend Knight 2023-07-28 Monthly 18 4.94%
EQL.TO Dividend Junior 2023-06-28 Quarterly 7 1.01%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.3571.500-7.15-10.00[0 - 0.5]
returnOnAssetsTTM-0.01521.200-0.505-0.606[0 - 0.3]
returnOnEquityTTM-0.02281.500-1.365-2.05[0.1 - 1]
payoutRatioTTM-4.42-1.000-10.0010.00[0 - 1]
currentRatioTTM1.1310.8009.347.48[1 - 3]
quickRatioTTM1.1310.8008.056.44[0.8 - 2.5]
cashRatioTTM0.8211.5006.559.82[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM8.882.007.0410.00[0 - 30]
freeCashFlowPerShareTTM8.882.005.5610.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM1.0001.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.5101.0001.8041.804[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM0.04240.800-3.05-2.44[0.5 - 2]
Total Score2.52

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-42.981.000-4.440[1 - 100]
returnOnEquityTTM-0.02282.50-0.877-2.05[0.1 - 1.5]
freeCashFlowPerShareTTM8.882.007.0410.00[0 - 30]
dividendYielPercentageTTM9.461.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM8.882.007.0410.00[0 - 30]
payoutRatioTTM-4.421.500-10.0010.00[0 - 1]
pegRatioTTM0.4061.500-0.6270[0.5 - 2]
operatingCashFlowSalesRatioTTM9.841.00010.000[0.1 - 0.5]
Total Score2.24

BIG PHARMA SPLIT CORP

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators